1. Home
  2. ONCY vs AMTX Comparison

ONCY vs AMTX Comparison

Compare ONCY & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.12

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.83

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
AMTX
Founded
1998
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
94.0M
98.6M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
ONCY
AMTX
Price
$1.12
$1.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$6.00
$17.00
AVG Volume (30 Days)
1.2M
860.1K
Earning Date
03-06-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$201,323,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$139.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$1.22
52 Week High
$1.51
$3.66

Technical Indicators

Market Signals
Indicator
ONCY
AMTX
Relative Strength Index (RSI) 54.97 64.39
Support Level $0.98 $1.43
Resistance Level $1.30 $1.62
Average True Range (ATR) 0.09 0.12
MACD 0.02 0.03
Stochastic Oscillator 52.63 97.67

Price Performance

Historical Comparison
ONCY
AMTX

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: